Insider Trading Alert - DECK, WLP And WMGI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 9, 2014, 87 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $201.24 to $22,465,418.44.

Highlighted Stocks Traded by Insiders:

Deckers Outdoor (DECK) - FREE Research Report

Powers David, who is President, Omni Channel at Deckers Outdoor, sold 1,041 shares at $81.34 on June 9, 2014. Following this transaction, the President, Omni Channel owned 23,833 shares meaning that the stake was reduced by 4.19% with the 1,041-share transaction.

The shares most recently traded at $81.65, up $0.31, or 0.38% since the insider transaction. Historical insider transactions for Deckers Outdoor go as follows:

  • 4-Week # shares sold: 3,512
  • 12-Week # shares sold: 3,512
  • 24-Week # shares sold: 21,541

The average volume for Deckers Outdoor has been 646,900 shares per day over the past 30 days. Deckers Outdoor has a market cap of $2.8 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are down 2.53% year-to-date as of the close of trading on Monday.

Deckers Outdoor Corporation designs, markets, and distributes footwear, apparel, and accessories for outdoor activities and casual lifestyle use for men, women, and children. The company has a P/E ratio of 20.1. Currently, there are 8 analysts who rate Deckers Outdoor a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DECK - FREE

TheStreet Quant Ratings rates Deckers Outdoor as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Deckers Outdoor Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

WellPoint (WLP) - FREE Research Report

Peru Ramiro G, who is Director at WellPoint, sold 5,372 shares at $108.42 on June 9, 2014. Following this transaction, the Director owned 20,686 shares meaning that the stake was reduced by 20.62% with the 5,372-share transaction.

The shares most recently traded at $105.16, down $3.26, or 3.1% since the insider transaction. Historical insider transactions for WellPoint go as follows:

  • 4-Week # shares sold: 5,661
  • 12-Week # shares sold: 5,661
  • 24-Week # shares sold: 25,661

The average volume for WellPoint has been 2.7 million shares per day over the past 30 days. WellPoint has a market cap of $29.7 billion and is part of the health care sector and health services industry. Shares are up 13.95% year-to-date as of the close of trading on Monday.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. The stock currently has a dividend yield of 1.65%. The company has a P/E ratio of 13.0. Currently, there are 7 analysts who rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WLP - FREE

TheStreet Quant Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Wright Medical Group (WMGI) - FREE Research Report

Andrews Julie, who is VP Fin. & Chief Acctg. Officer at Wright Medical Group, sold 106 shares at $30.39 on June 9, 2014. Following this transaction, the VP Fin. & Chief Acctg. Officer owned 15,873 shares meaning that the stake was reduced by 0.66% with the 106-share transaction.

The shares most recently traded at $30.72, up $0.33, or 1.07% since the insider transaction. Historical insider transactions for Wright Medical Group go as follows:

  • 4-Week # shares sold: 7,895
  • 12-Week # shares sold: 15,294
  • 24-Week # shares sold: 3.0 million

The average volume for Wright Medical Group has been 581,600 shares per day over the past 30 days. Wright Medical Group has a market cap of $1.5 billion and is part of the health care sector and health services industry. Shares are up 0.1% year-to-date as of the close of trading on Monday.

Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles. Currently, there are 7 analysts who rate Wright Medical Group a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WMGI - FREE

TheStreet Quant Ratings rates Wright Medical Group as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share. Get the full Wright Medical Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists